Lv11
22 积分 2026-03-27 加入
Diffuse Large B-Cell Lymphoma
8小时前
待确认
Bispecific Antibody Ivonescimab Added to Chemotherapy in EGFR-Variant Non-Small Cell Lung Cancer: The HARMONi-A Randomized Clinical Trial
1个月前
已完结
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy in advanced squamous non-small-cell lung cancer (HARMONi-6): interim overall survival analysis of a randomised, double-blind, phase 3 trial in China
1个月前
已完结
Intismeran Autogene Plus Pembrolizumab Versus Pembrolizumab Alone in High-Risk Resected Melanoma: 5-Year Update of the Randomized Phase 2b KEYNOTE-942 Study
1个月前
已关闭
Artificial intelligence in drug development
1个月前
已完结
Long-Term Survival of Hypoimmune Allogeneic Islets without Immunosuppression
1个月前
已完结
Targeting ClpP Protease: Emerging Therapeutic Strategies and Small-Molecule Modulators in Drug Discovery
1个月前
已完结
Zodasiran, an RNAi Therapeutic Targeting ANGPTL3, for Mixed Hyperlipidemia
2个月前
已完结
Efficacy of evinacumab in patients with severe hypertriglyceridemia and a history of severe hypertriglyceridemia-related acute pancreatitis: A phase 2b trial
2个月前
已完结
Plozasiran Across a Spectrum of Hypertriglyceridemia: Final Long-Term Efficacy and Safety Results From an Open-Label Extension Study
2个月前
已完结
皖公网安备34019202002308
